T1	Participants 82 117	in childhood and adolescent autism.
T2	Participants 449 470	children with autism.
T3	Participants 572 654	repetitive behaviors in childhood and adolescent autism spectrum disorders (ASDs).
T4	Participants 665 825	45 child or adolescent patients with ASD were randomized into two acute 8-week phases in a double-blind placebo-controlled crossover study of liquid fluoxetine.
T5	Participants 1128 1148	repetitive behaviors
